X-rays-induced_JJ
secretion_NN
of_IN
cellular_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
that_WDT
enhance_VBP
-LRB-_-LRB-
s_VBZ
-RRB-_-RRB-
HIV-1_NN
promoter_NN
transcription_NN
in_IN
various_JJ
non-irradiated_JJ
transfected_VBN
cell_NN
lines_NNS
._.

Various_JJ
cellular_JJ
stress_NN
agents_NNS
like_IN
ionizing_VBG
radiation_NN
exposure_NN
could_MD
activate_VB
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
replication_NN
or_CC
reporter_NN
gene_NN
expression_NN
._.

In_IN
addition_NN
,_,
extracellular_JJ
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
released_VBN
by_IN
X-ray-treated_JJ
human_JJ
colonic_JJ
carcinoma_NN
cell_NN
line_NN
-LRB-_-LRB-
HT29_NN
-RRB-_-RRB-
might_MD
activate_VB
the_DT
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
of_IN
HIV-1_NN
in_IN
non-irradiated_JJ
HT29_NN
cells_NNS
._.

In_IN
the_DT
present_JJ
report_NN
we_PRP
show_VBP
that_IN
in_IN
various_JJ
transiently_RB
or_CC
stably_RB
transfected_VBN
cell_NN
lines_NNS
,_,
X-ray_NN
irradiation_NN
up-regulates_VBZ
HIV-1_NN
LTR_NN
transcription_NN
through_IN
the_DT
kappaB_NN
regulatory_JJ
elements_NNS
._.

A_DT
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
,_,
which_WDT
is_VBZ
processed_VBN
by_IN
and_CC
acts_VBZ
upon_IN
a_DT
variety_NN
of_IN
cell_NN
types_NNS
,_,
was_VBD
detected_VBN
by_IN
addition_NN
to_TO
non-irradiated_JJ
cells_NNS
of_IN
either_CC
X-ray-treated_JJ
cells_NNS
or_CC
a_DT
conditioned_JJ
medium_NN
taken_VBN
from_IN
irradiated_JJ
cultures_NNS
._.

The_DT
magnitude_NN
of_IN
responsiveness_NN
is_VBZ
cell_NN
type_NN
dependent_JJ
._.

In_IN
addition_NN
,_,
X-ray_NN
activation_NN
of_IN
HIV-1_NN
LTR_NN
in_IN
transiently_RB
or_CC
stably_RB
transfected_VBN
cell_NN
lines_NNS
is_VBZ
inhibited_VBN
by_IN
a_DT
potent_JJ
antioxidant_JJ
drug_NN
,_,
pyrrolidine_NN
dithiocarbamate_NN
and_CC
by_IN
another_DT
drug_NN
,_,
known_VBN
for_IN
its_PRP$
role_NN
in_IN
the_DT
trapping_NN
of_IN
growth_NN
factors_NNS
,_,
suramin_NN
._.

The_DT
importance_NN
of_IN
these_DT
observations_NNS
in_IN
the_DT
pathophysiology_NN
of_IN
patients_NNS
with_IN
AIDS-related_JJ
cancers_NNS
treated_VBN
by_IN
radiotherapy_NN
remains_VBZ
to_TO
be_VB
established_VBN
._.

